1 In vitro and in vivo inhibition of ortho- and paramyxovirus infections by a new class of sulfonic acid polymers interacting with virus-cell binding and/or fusion

2 ACUTE RESPIRATORY DISEASE IN INFANCY AND CHILDHOOD: PRESENT UNDERSTANDING AND PROSPECTS FOR PREVENTION

3 Maternal influenza and birth outcomes: systematic review of comparative studies

4 Interferon production in children with respiratory syncytial, influenza, and parainfluenza virus infections

5 Clinical and epidemiological characterization of influenza virus infections in children with severe acute respiratory infection in Maputo, Mozambique: Results from the implementation of sentinel surveillance, 2014 - 2016

6 Epidemiology of acute lower respiratory disease in children

7 An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines

8 Profile: the KEMRI/CDC Health and Demographic Surveillance System--Western Kenya

9 Interferon in nasal secretions from infants with viral respiratory tract infections

10 mx bio adjuvant for enhancing immune responses against influenza virus

11 H5N1 infection of the respiratory tract and beyond: a molecular pathology study

12 Viral load in patients infected with pandemic H1N1 2009 influenza A virus

13 Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus

14 Geographic dependence, surveillance, and origins of the 2009 influenza A (H1N1) virus

15 The US Influenza Hospitalization Surveillance Network

16 Differential susceptibility of different cell lines to swine-origin influenza A H1N1, seasonal human influenza A H1N1, and avian influenza A H5N1 viruses

17 Influenza Vaccination Modifies Disease Severity Among Community-dwelling Adults Hospitalized With Influenza

18 Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome

19 Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009

20 Spread of influenza A virus infection in hospitalised patients with cancer

21 Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination

22 Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets

23 Monitoring of neuraminidase inhibitor resistance among clinical influenza virus isolates in Japan during the 2003-2006 influenza seasons

24 Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study

25 Does Influenza Vaccination Modify Influenza Severity? Data on Older Adults Hospitalized With Influenza During the 2012-2013 Season in the United States

26 Safety and tolerability of oseltamivir prophylaxis in hematopoietic stem cell transplant recipients: a retrospective case-control study

27 Resistant influenza A viruses in children treated with oseltamivir: descriptive study

28 Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection

29 The pathology of influenza virus infections

30 Treatment of influenza with neuraminidase inhibitors: virological implications

31 High frequency of resistant viruses harboring different mutations in amantadine-treated children with influenza

32 Influenza vaccination for immunocompromised patients: summary of a systematic review and meta-analysis

33 The natural history of influenza infection in the severely immunocompromised vs nonimmunocompromised hosts

34 Adult hospitalizations for laboratory-positive influenza during the 2005-2006 through 2007-2008 seasons in the United States

35 Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center

36 Factors associated with early hospital discharge of adult influenza patients

37 Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature

38 Oral oseltamivir treatment of influenza in children

39 Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice

40 Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults

41 Evaluation of intravenous zanamivir against experimental influenza A (H5N1) virus infection in cynomolgus macaques

42 Avian influenza virus infections in humans

43 Oseltamivir is adequately absorbed following nasogastric administration to adult patients with severe H5N1 influenza

44 Epidemiology of influenza A virus infection in patients with acute or chronic leukemia

45 Annual estimates of the burden of seasonal influenza in the United States: A tool for strengthening influenza surveillance and preparedness

46 Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine

47 Influenza A and B virus infections in children

48 Comparison of clinical features and outcomes of medically attended influenza A and influenza B in a defined population over four seasons: 2004-2005 through 2007-2008

49 The Southeast Asian Influenza Clinical Research Network: development and challenges for a new multilateral research endeavor

50 In vitro and in vivo activities of anti-influenza virus compound T-705

51 Rapid and sensitive method using multiplex real-time PCR for diagnosis of infections by influenza a and influenza B viruses, respiratory syncytial virus, and parainfluenza viruses 1, 2, 3, and 4

52 Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods

53 Myocardial injury and bacterial pneumonia contribute to the pathogenesis of fatal influenza B virus infection

54 Confirmation of the first Hong Kong case of human infection by novel swine origin influenza A (H1N1) virus diagnosed using ultrarapid, real-time reverse transcriptase PCR

55 A 5-Year Prospective Multicenter Evaluation of Influenza Infection in Transplant Recipients

56 Outcomes of adults hospitalised with severe influenza

57 Use of influenza antivirals during 2003-2004 and monitoring of neuraminidase inhibitor resistance

58 Bigger and Better? Representativeness of the Influenza A Surveillance Using One Consolidated Clinical Microbiology Laboratory Data Set as Compared to the Belgian Sentinel Network of Laboratories.

59 Silver nanoparticle-adjuvanted vaccine protects against lethal influenza infection through inducing BALT and IgA-mediated mucosal immunity.

60 Poultry trading behaviours in Vietnamese live bird markets as risk factors for avian influenza infection in chickens.

61 Pandemic (H1N1) influenza in Diyarbakir, 2009

62 Epidemiological and molecular analysis of avian influenza A(H7N9) virus in Shanghai, China, 2013–2017

63 Antiviral resistance markers in influenza virus sequences in Mexico, 2000–2017

64 Health-seeking behavior and transmission dynamics in the control of influenza infection among different age groups

65 Assessing the oseltamivir-induced resistance risk and implications for influenza infection control strategies

66 Drug resistance in influenza A virus: the epidemiology and management

67 Post-influenza aspergillosis, do not underestimate influenza B

68 Peramivir injection in the treatment of acute influenza: a review of the literature

69 Modeling human influenza infection in the laboratory

70 Acceptance of a pandemic influenza vaccine: a systematic review of surveys of the general public

71 Antimicrobial susceptibility among Streptococcus pneumoniae and Haemophilus influenzae collected globally between 2015 and 2017 as part of the Tigecycline Evaluation and Surveillance Trial (TEST)

72 Poly-ADP Ribosyl Polymerase 1 (PARP1) Regulates Influenza A Virus Polymerase

73 Epidemiological and molecular analysis of avian influenza A(H7N9) virus in Shanghai, China, 2013–2017

74 Antiviral resistance markers in influenza virus sequences in Mexico, 2000–2017

75 Health-seeking behavior and transmission dynamics in the control of influenza infection among different age groups

76 Assessing the oseltamivir-induced resistance risk and implications for influenza infection control strategies

77 Drug resistance in influenza A virus: the epidemiology and management

78 Post-influenza aspergillosis, do not underestimate influenza B

79 Peramivir injection in the treatment of acute influenza: a review of the literature

80 Modeling human influenza infection in the laboratory

81 Acceptance of a pandemic influenza vaccine: a systematic review of surveys of the general public

82 Isolation and Antibiotic Susceptibility Testing of Haemophilus influenzae from Nasopharynx of Children under Five Years Attending Maternal and Child Health Clinic in Mbarara Regional Referral Hospital

83 Combination therapy targeting platelet activation and virus replication protects mice against lethal influenza pneumonia.

84 Analytical performances of the BD Veritor™ System for the detection of respiratory syncytial virus and influenzaviruses A and B when used at bedside in the pediatric emergency department.

85 Report on Influenza A and B Viruses: Their Coinfection in a Saudi Leukemia Patient

86 Observer-Based Adaptive PI Sliding Mode Control of Developed Uncertain SEIAR Influenza Epidemic Model Considering Dynamic Population.

87 Editorial: Epidemiology of Avian Influenza Viruses.

88 Protection of wetlands as a strategy for reducing the spread of avian influenza from migratory waterfowl.

89 Polygalasaponin F treats mice with pneumonia induced by influenza virus.

90 A Perfect Storm: Increased Colonization and Failure of Vaccination Leads to Severe Secondary Bacterial Infection in Influenza Virus-Infected Obese Mice

91 Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans.

92 A Randomized, Double-blind, Active-controlled Phase III Trial of a Cell Culture-derived Quadrivalent Inactivated Influenza Vaccine in Healthy South Korean Children and Adolescents 6 Months to 18 Years of Age.

93 Selective Capture and Determination of Receptor-Binding Hemagglutinin in Influenza Vaccine Preparations Using a Coupled Receptor-Binding/RP-HPLC Assay

94 A qualitative study of pandemic influenza preparedness among small and medium-sized businesses in New York City.

95 Determinants of Seasonal Influenza Vaccine Uptake Among the Elderly in the United States: A Systematic Review and Meta-Analysis.

96 CD206+ Cell Number Differentiates Influenza A (H1N1)pdm09 from Seasonal Influenza A Virus in Fatal Cases

97 Health information technology use and influenza vaccine uptake among US adults.

98 Spatio-Temporal Occurrence Modeling of Highly Pathogenic Avian Influenza Subtype H5N1: A Case Study in the Red River Delta, Vietnam

99 Glycan-immobilized dual-channel field effect transistor biosensor for the rapid identification of pandemic influenza viral particles

100 Invasive Salmonella Enteritidis infection complicated by bacterial meningitis and vertebral osteomyelitis shortly after influenza A infection in an immunocompetent young adult.

101 Pregnancy-related immune suppression leads to altered influenza vaccine recall responses.

Keyword Connections

Journals

Research Groups

Bibliographies